ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415,417 | -18.7% | 204,639 | -7.9% | 0.00% | – |
| Q2 2023 | $510,867 | -37.7% | 222,116 | -17.9% | 0.00% | – |
| Q1 2023 | $819,897 | -8.4% | 270,593 | -29.5% | 0.00% | – |
| Q4 2022 | $894,653 | -28.0% | 383,971 | -41.0% | 0.00% | – |
| Q3 2022 | $1,243,000 | -37.3% | 651,036 | -11.0% | 0.00% | – |
| Q2 2022 | $1,982,000 | -56.8% | 731,165 | -52.6% | 0.00% | -100.0% |
| Q1 2022 | $4,592,000 | +70.3% | 1,541,185 | +122.3% | 0.00% | 0.0% |
| Q4 2021 | $2,697,000 | +119.3% | 693,271 | +141.9% | 0.00% | – |
| Q3 2021 | $1,230,000 | +288.0% | 286,636 | +174.3% | 0.00% | – |
| Q2 2021 | $317,000 | +112.8% | 104,484 | +134.1% | 0.00% | – |
| Q1 2021 | $149,000 | -29.0% | 44,639 | -24.7% | 0.00% | – |
| Q4 2020 | $210,000 | -73.6% | 59,250 | -76.7% | 0.00% | – |
| Q3 2020 | $795,000 | -73.8% | 254,115 | -84.7% | 0.00% | -100.0% |
| Q2 2020 | $3,029,000 | +54.7% | 1,664,331 | -14.1% | 0.00% | 0.0% |
| Q1 2020 | $1,958,000 | +719.2% | 1,938,329 | +2151.5% | 0.00% | – |
| Q4 2019 | $239,000 | +50.3% | 86,091 | -17.4% | 0.00% | – |
| Q3 2019 | $159,000 | -62.0% | 104,228 | -48.1% | 0.00% | – |
| Q2 2019 | $418,000 | -47.1% | 200,736 | -9.0% | 0.00% | – |
| Q1 2019 | $790,000 | +136.5% | 220,650 | +152.5% | 0.00% | – |
| Q4 2018 | $334,000 | -61.0% | 87,397 | -3.5% | 0.00% | – |
| Q3 2018 | $856,000 | -66.8% | 90,592 | -74.4% | 0.00% | -100.0% |
| Q2 2018 | $2,579,000 | +383.9% | 353,338 | +231.2% | 0.00% | – |
| Q1 2018 | $533,000 | +93.8% | 106,670 | +95.6% | 0.00% | – |
| Q4 2017 | $275,000 | -16.7% | 54,522 | -40.5% | 0.00% | – |
| Q2 2017 | $330,000 | -58.0% | 91,706 | -62.1% | 0.00% | – |
| Q1 2017 | $785,000 | -12.0% | 241,676 | -33.6% | 0.00% | – |
| Q4 2016 | $892,000 | -57.5% | 364,146 | -40.3% | 0.00% | -100.0% |
| Q3 2016 | $2,100,000 | -11.3% | 610,448 | -10.3% | 0.00% | 0.0% |
| Q2 2016 | $2,368,000 | -23.4% | 680,546 | -9.1% | 0.00% | 0.0% |
| Q1 2016 | $3,092,000 | +2.9% | 748,731 | +10.9% | 0.00% | 0.0% |
| Q4 2015 | $3,004,000 | -30.0% | 675,056 | -4.2% | 0.00% | 0.0% |
| Q3 2015 | $4,291,000 | – | 704,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |